Essential Drugs List - Fourth Revision 2003 - Federal Republic of Nigeria: V. LIST OF ESSENTIAL DRUGS: 6 ANTI-INFECTIVE DRUGS: 6.13 Antiretroviral (ARV) Drugs: 6.13.2 Nucleoside Reverse Transcriptase Inhibitors

Home page | Help | Clear

English | French

Search | Categories | Titles A-Z | Countries | Compare countries | Index

Expand Document

Printable HTML version

Export document as HTML file Help


	Essential Drugs List - Fourth Revision 2003 - Federal Republic of Nigeria (The Federal Ministry of Health N, WHO; 2003; 50 pages)
		I. FOREWORD
		II. PREFACE TO THE FOURTH REVISION
		III. NATIONAL DRUG FORMULARY AND ESSENTIAL DRUGS LIST REVIEW COMMITTEE 1999 - 2002
		V. LIST OF ESSENTIAL DRUGS
			1. ANAESTHETICS
				1.1 General Anaesthetics and Oxygen
				1.2 Premedication Drugs And Analgesic Adjuvants
				1.3 Skeletal Muscle Relaxants and Antagonists
				1.4 Local Anaesthetics
			2. ANALGESICS, ANTIPYRETICS AND NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
				2.1 Narcotic Analgesics
				2.2 Narcotic Antagonist
				2.3 Non-narcotic Analgesics and Antipyretics
				2.4 Non-steroidal Anti-inflammatory Drugs and Drugs used for Gout
			3 ANTI-ALLERGICS
				3.1 Antihistamines
				3.2 Anti-anaphylactics
			4 ANTIDOTES
				4.1 Non-specific (General) Antidotes
				4.2 Specific Antidotes
			5 ANTICONVULSANTS (ANTI-EPILEPTICS)
			6 ANTI-INFECTIVE DRUGS
				6.1 Amoebicides
				6.2 Anthelmintics
				6.3 Antifilarial Drugs
				6.4 Antischistosomal Drugs
				6.5 Antitrypanosomal and Antileishmaniasis Drugs
				6.6 Antimalarial Drugs
				6.7 Antiflagellate Drugs
				6.8 Antibacterial Drugs
				6.9 Antileprosy Drugs
				6.10 Antituberculosis Drugs
				6.11 Systemic Antifungal Drugs
				6.12 Antiviral Drugs
				6.13 Antiretroviral (ARV) Drugs
					6.13.1 Protease Inhibitors
					6.13.2 Nucleoside Reverse Transcriptase Inhibitors
					6.13.3 Non-nucleoside Reverse Transcriptase Inhibitors
			7. ANTIMIGRAINE DRUGS
			8. ANTINEOPLASTIC AND IMMUNOSUPPRESSIVE DRUGS
			9. DRUGS FOR PARKINSONISM AND OTHER NEUROLOGICAL DISORDERS
				9.1 Antiparkinsonism Drugs
				9.2 Drugs for Myasthenia Gravis
				9.3 Drug for Subarachnoid Haemorrhage
			10. ANTISEPTICS AND DISINFECTANTS
			11. DRUGS AFFECTING THE BLOOD
				11.1 Anti-anaemia Drugs
				11.2 Anticoagulants and Antiplatelets
				11.3 Antifibrinolytic and Haemostatic Drug
				11.4 Plasma Substitutes
				11.5 Plasma Fraction for Specific Use
			12. CARDIOVASCULAR DRUGS
				12.1 Anti-anginal Drugs
				12.2 Anti-arrhythmic Drugs
				12.3 Antihypertensive Drugs
				12.4 Medicines Used in Heart Failure
			13. DENTAL DRUGS
				13.1 Local Anaesthetics
				13.2 Mouthwashes
				13.3 Anti-inflammatory Dental Drugs
			14. DERMATOLOGICAL DRUGS
				14.1 Anti-infective Drugs
				14.2 Anti-inflammatory and Antipruritic Drugs
				14.3 Astringent Drugs
				14.4 Anti-acne Drugs
				14.5 Antifungal Drugs
				14.6 Keratolytic And Keratoplastic Drugs
				14.7 Scabicides and Pediculicides
			15. IN VIVO DIAGNOSTIC AGENTS
				15.1 Radio-contrast Media
					15.1.1 Alimentary Tract
					15.1.2 Angiography
					15.1.3 Bronchography
					15.1.4 Cholecystography (Oral)
					15.1.5 Cholecystography (Intravenous)
					15.1.6 Myelography
					15.1.7 Urography
				15.2 Tuberculosis
			16. DIURETICS
			17. EAR, NOSE AND THROAT DRUGS
				17.1 Ear Drugs
					17.1.1 Anti-infective Drugs
					17.1.2 Anti-inflammatory Drug
					17.1.3 Combined Anti-infective and Anti-inflammatory Drugs
					17.1.4 Removal of Ear Wax Preparations
				17.2 Nose Drugs
					17.2.1 Anti-allergic and Nasal Decongestants (Topical and Systemic)
					17.2.2 Cauterization of Nose Preparations
			18. GASTRO-INTESTINAL DRUGS
				18.1 Antacid Drugs
				18.2 Anti-emetic Drugs
				18.3 Anti-haemorrhoidal Drugs
				18.4 Antispasmodic Drugs and Smooth Muscle Stimulants
				18.5 Laxatives
				18.6 Anti-diarrhoeal Drugs
					18.6.1 Symptomatic Drug
					18.6.2 Replacement Fluid (Oral Rehydration Therapy)
				18.7 Peptic Ulcer Drugs
			19. HORMONES AND SYNTHETIC SUBSTITUTES
				19.1 Corticosterids and Synthetic Substitutes
				19.2 Oestrogens
				19.3 Progestogens
				19.4 Contraceptives
					19.4.1 Oral Contraceptives
					19.4.2 Injectable Contraceptives
					19.4.3 Intrauterine Contraceptive Devices (IUCD)
					19.4.4 Barrier Methods
				19.5 Drugs Acting on Pituitary Ovarian Axis
				19.6 Antidiabetic Drugs
					19.6.1 Insulins
					19.6.2 Oral Antidiabetic Drugs
				19.7 Thyroid Hormones and Antithyroid Drugs
					19.7.1 Thryroid Hormone
					19.7.2 Antithyroid Drugs
			20. IMMUNOLOGICALS
				20.1 Sera and Immunoglobulins
				20.2 Vaccines
					20.2.1 Vaccines for Universal Immunization
					20.2.2 Vaccines for Specific Immunization
			21. OPHTHALMOLOGICAL DRUGS
				21.1 Anti-infective Drugs
				21.2 Anti-inflammatory and Anti-allergic Drugs
				21.3 Local Anaesthetics
				21.4 Miotics and Antiglaucoma Drugs
					21.4.1 Topical Drugs
					21.4.2 Systemic Drugs
				21.5 Mydriatic Drugs
				21.6 Diagnostic Eye Drug
				21.7 Miscellaneous Eye Preparations
			22. OXYTOCICS AND TOCOLYTICS
			23. PERITONEAL DIALYSIS SOLUTIONS
			24. PREPARATIONS FOR CORRECTING WATER, ELECTROLYTE AND ACID-BASE DISTURBANCES
				24.1 Oral Preparations
				24.2 Parenteral Preparations
			25. PSYCHOTHERAPEUTIC DRUGS
				25.1 Hypnotics and Sedatives
				25.2 Tricyclic Antidepressants
				25.3 Antipsychotics (Major Tranquilizers)
				25.4 Antidotes to Antipsychotic Drugs
			26. RESPIRATORY SYSTEM DRUGS
				26.1 Anti-asthmatic Drugs
				26.2 Antitussives, Expectorants and Mucolytics
			27. VITAMINS AND MINERALS
				27.1 Vitamins
				27.2 Minerals
		VI. THE PRIMARY HEALTH CARE LIST
		VII. LIST OF PRODUCTS TO BE STOCKED AND SOLD BY PATENT MEDICINE DEALERS/VENDORS
		VIII. CHANGES MADE IN REVISING THE LIST
			Appendix 1 Approved Doses for Vitamins
			Appendix 2 Restricted List of Drugs

6.13.2 Nucleoside Reverse Transcriptase Inhibitors

Name of Drug		Dosage Forms and Strength
Lamivudine	-	Tablet, 150 mg
	-	Solution, 5 mg/mL
	-	Injection,
Stavudine	-	Tablet, 40 mg
Zidovudine	-	Capsule, 100 mg, 250 mg
	-	Syrup, 50 mg/mL

Please provide your feedback

English | French